MedPath

Hypertension in Hemodialysis

Not Applicable
Completed
Conditions
Hypertension
Left Ventricular Hypertrophy
Registration Number
NCT00067665
Lead Sponsor
Indiana University
Brief Summary

How high blood pressure in hemodialysis patients should be diagnosed and treated using medications or without medications is the purpose of this study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The primary outcome parameter will be systolic reduction in 44h-interdialytic ambulatory BP with ultrafiltration as compared to the control group by intention to treat analysis0, 4, 8 wks
Secondary Outcome Measures
NameTimeMethod
Per protocol analysis of primary outcome with 1. weight loss as the covariate. 2. baseline left-atrial size and weight loss as covariates.3. Others: (Description restricted by space limitation)0, 4, 8 wks

Trial Locations

Locations (1)

Indiana University Affiliated Dialysis Unit

🇺🇸

Indianapolis, Indiana, United States

Indiana University Affiliated Dialysis Unit
🇺🇸Indianapolis, Indiana, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.